In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In the days leading up to President Trump’s inauguration, the Biden FTC rushed to initiate major lawsuits and to tie a bow on ...

As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...

LUBBOCK, Texas — Prescription drug prices are rising, and a new report from the Federal Trade Commission (FTC) explains why. Pharmacy benefit managers (PBM) are being blamed for driving up costs.

General Motors has agreed to a settlement with the Federal Trade Commission, the agency said Thursday, over allegations the automaker is sharing the precise location and driving behavior data of ...

In a new report, the Federal Trade Commission is charging OptumRx, UHC's pharmacy benefit manager (PBM), with inflating the cost of "numerous specialty generic drugs... by thousands of percent ...

PBM's serve as middlemen between drug makers, insurers, and pharmacies. A new report from the FTC claims the companies made more than seven-billion dollars by marking up the prices of generic ...

America's largest health care company, UnitedHealth, made profits of more than 5,000 percent on a lifesaving leukemia drug, according to a Federal Trade Commission report. The December murder of ...

As many as 1 in 4 insulin users report rationing their insulin ... In Sept. 2024, the Federal Trade Commission sued what's known as the "Big Three" of pharmacy benefit managers, accusing them ...

The findings are part of an investigation into pharmacy benefit managers, or PBMs, that was undertaken by the FTC in 2022. Tuesday’s was the second interim report issued in the probe. One issued last ...

In a new report, the Federal Trade Commission is charging OptumRx, UHC's pharmacy benefit manager (PBM), with inflating the cost of "numerous specialty generic drugs... by thousands of percent, and ...